Morgan Stanley sees record year for Hong Kong IPOs as pipeline hits 450

Cathy Zhang, head of Asia-Pacific equity capital markets at Morgan Stanley, predicts that 2026 could exceed last year's record IPO figures in Hong Kong, driven by January's momentum, with more than 450 companies already in the pipeline.

Cathy Zhang, head of Asia-Pacific equity capital markets at Morgan Stanley, sounded hoarse after back-to-back meetings with companies eager to go public in Hong Kong. “It’s very possible that the value and number may exceed last year’s IPO figures, given the momentum we have seen in January,” Zhang said in an interview on January 30.

Nearly 100 companies filed for stock offerings in the city last month, more than triple the same period in 2025, a year which saw Hong Kong crowned as the world’s top IPO venue with 114 listings that raised US$37.2 billion over the whole year. More than 450 companies are already in the pipeline for 2026.

“This year definitely has a stronger start. … [It] is the busiest ever when I compare it to the last 20 years in Hong Kong,” Zhang said. “The pipeline will be more diversified across different sectors compared with last year. Tech, healthcare and industrials are expected to be the three most active sectors.”

Many artificial intelligence and robotics companies were also coming to the market, including humanoid and traditional industrial robot makers, alongside firms in industrial automation and players in clean and new energy, according to Zhang. Mainland China’s issuers will still dominate the city’s IPO market, but US and Southeast Asian companies are also joining in.

This outlook underscores Hong Kong's enduring appeal as a global IPO hub, promising greater sectoral diversity. (Word count: 218)

Verwandte Artikel

Trading floor at Jakarta Stock Exchange showing advancing Asian markets with IHSG caution amid rupiah weakness and fiscal warnings.
Bild generiert von KI

Asiatische Märkte steigen zum Eröffnungshandel, IHSG vor Korrektur

Von KI berichtet Bild generiert von KI

Asiatisch-pazifische Aktienmärkte legten am Montag, dem 22. Dezember 2025, zu Beginn des Handels zu, während Anleger auf die Zinssatzentscheidung Chinas warteten. In Indonesien eröffnete der IHSG 0,23 Prozent höher bei 8.629, obwohl eine Korrektur aufgrund der Schwächung der Rupiah erwartet wird. Die Warnung der Weltbank vor dem Fiskaldefizit Indonesiens beeinflusste ebenfalls die Marktstimmung.

New share listings by Chinese technology firms in Hong Kong have delivered above-average returns on their debuts so far in 2026, as investors bet on Beijing’s push for technology self-reliance amid a challenging macro environment. The outperformance underlines that the tech self-reliance trade is extending its momentum into 2026, the first year of China’s latest five-year development plan, which emphasises artificial intelligence and other cutting-edge technologies.

Von KI berichtet

While the underperformance of Chinese equities in the last financial quarter warrants scrutiny, overall gains are likely to continue in 2026. Most Wall Street banks remain bullish on Chinese stocks, though some have turned more cautious. China's stock market saw a strong rebound in 2025, with Hong Kong emerging as Asia's top fundraising venue.

Global institutional investors have built sizeable positions in China's largest biotech firms, including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne. These companies, all constituents of the Hang Seng Biotech Index, are gaining importance on the global stage. Foreign investors, from sovereign wealth funds to industry players, are securing strategic stakes in their future success.

Von KI berichtet

Chinese chip designer GigaDevice debuted on the Hong Kong exchange with shares surging, fueled by investors' enthusiasm for Beijing's self-reliance push. Retail demand was oversubscribed more than 540 times, driving the strong performance.

Transaction volume for deals involving Japanese companies approached $350 billion by the end of 2025, marking a record year. Corporate governance reforms aimed at improving shareholder returns have fueled this surge. Next year is expected to be even busier.

Von KI berichtet

Despite a bitcoin price correction of over 30%, 2025's $8.6 billion crypto mergers boom—driven by license acquisitions amid Trump-era deregulation—continued apace, with analysts predicting persistence into 2026. This complemented $14.6 billion in IPOs, signaling industry maturation.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen